Enabling formulations for PROTACs: A line-of-sight to clinic
Fields of Study & Subjects
Protein Degradation and Inhibitors
HER2/EGFR in Cancer Research
Receptor Mechanisms and Signaling
Publication details
- Journal / source
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Volume
- 237
- Pages
- 115927–115927
- Publication date
- 9 July 2026
- Language
- EN